EYEPOINT INC (EYPT) Fundamental Analysis & Valuation

NASDAQ:EYPT • US30233G2093

Current stock price

14.23 USD
+0.06 (+0.42%)
At close:
14.06 USD
-0.17 (-1.19%)
After Hours:

This EYPT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. EYPT Profitability Analysis

1.1 Basic Checks

  • EYPT had negative earnings in the past year.
  • EYPT had a negative operating cash flow in the past year.
  • EYPT had negative earnings in each of the past 5 years.
  • EYPT had negative operating cash flow in 4 of the past 5 years.
EYPT Yearly Net Income VS EBIT VS OCF VS FCFEYPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -63.73%, EYPT is doing worse than 70.31% of the companies in the same industry.
  • With a Return On Equity value of -75.78%, EYPT perfoms like the industry average, outperforming 40.10% of the companies in the same industry.
Industry RankSector Rank
ROA -63.73%
ROE -75.78%
ROIC N/A
ROA(3y)-38.31%
ROA(5y)-38.76%
ROE(3y)-47.08%
ROE(5y)-55.8%
ROIC(3y)N/A
ROIC(5y)N/A
EYPT Yearly ROA, ROE, ROICEYPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • EYPT's Gross Margin of 93.41% is amongst the best of the industry. EYPT outperforms 94.79% of its industry peers.
  • In the last couple of years the Gross Margin of EYPT has grown nicely.
  • The Profit Margin and Operating Margin are not available for EYPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.35%
GM growth 5Y2.37%
EYPT Yearly Profit, Operating, Gross MarginsEYPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. EYPT Health Analysis

2.1 Basic Checks

  • EYPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EYPT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for EYPT has been increased compared to 5 years ago.
  • There is no outstanding debt for EYPT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EYPT Yearly Shares OutstandingEYPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
EYPT Yearly Total Debt VS Total AssetsEYPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 6.85 indicates that EYPT is not in any danger for bankruptcy at the moment.
  • EYPT has a better Altman-Z score (6.85) than 81.25% of its industry peers.
  • EYPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.85
ROIC/WACCN/A
WACC9.18%
EYPT Yearly LT Debt VS Equity VS FCFEYPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M 300M

2.3 Liquidity

  • EYPT has a Current Ratio of 8.88. This indicates that EYPT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 8.88, EYPT is doing good in the industry, outperforming 79.69% of the companies in the same industry.
  • A Quick Ratio of 8.83 indicates that EYPT has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 8.83, EYPT is in the better half of the industry, outperforming 79.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.88
Quick Ratio 8.83
EYPT Yearly Current Assets VS Current LiabilitesEYPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. EYPT Growth Analysis

3.1 Past

  • The earnings per share for EYPT have decreased strongly by -36.80% in the last year.
  • Looking at the last year, EYPT shows a very negative growth in Revenue. The Revenue has decreased by -27.50% in the last year.
  • Measured over the past years, EYPT shows a decrease in Revenue. The Revenue has been decreasing by -1.85% on average per year.
EPS 1Y (TTM)-36.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.56%
Revenue 1Y (TTM)-27.5%
Revenue growth 3Y-8.83%
Revenue growth 5Y-1.85%
Sales Q2Q%-94.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.39% on average over the next years. This is a very strong growth
  • EYPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 94.23% yearly.
EPS Next Y3.89%
EPS Next 2Y6.13%
EPS Next 3Y21.86%
EPS Next 5Y26.39%
Revenue Next Year-85.73%
Revenue Next 2Y17.25%
Revenue Next 3Y114.24%
Revenue Next 5Y94.23%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EYPT Yearly Revenue VS EstimatesEYPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B
EYPT Yearly EPS VS EstimatesEYPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

1

4. EYPT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EYPT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EYPT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EYPT Price Earnings VS Forward Price EarningsEYPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EYPT Per share dataEYPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EYPT's earnings are expected to grow with 21.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.13%
EPS Next 3Y21.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EYPT Dividend Analysis

5.1 Amount

  • EYPT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EYPT Fundamentals: All Metrics, Ratios and Statistics

EYEPOINT INC

NASDAQ:EYPT (4/9/2026, 8:25:43 PM)

After market: 14.06 -0.17 (-1.19%)

14.23

+0.06 (+0.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners101.61%
Inst Owner Change0%
Ins Owners2.96%
Ins Owner Change0.21%
Market Cap1.19B
Revenue(TTM)31.37M
Net Income(TTM)-231.96M
Analysts85.56
Price Target38.17 (168.24%)
Short Float %16.05%
Short Ratio8.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.19%
Min EPS beat(2)-6.2%
Max EPS beat(2)-6.19%
EPS beat(4)1
Avg EPS beat(4)-3.54%
Min EPS beat(4)-6.2%
Max EPS beat(4)2.78%
EPS beat(8)2
Avg EPS beat(8)-9.04%
EPS beat(12)5
Avg EPS beat(12)-15.19%
EPS beat(16)8
Avg EPS beat(16)-14.38%
Revenue beat(2)0
Avg Revenue beat(2)-55.68%
Min Revenue beat(2)-71.55%
Max Revenue beat(2)-39.81%
Revenue beat(4)1
Avg Revenue beat(4)17.01%
Min Revenue beat(4)-71.55%
Max Revenue beat(4)200.52%
Revenue beat(8)4
Avg Revenue beat(8)10.56%
Revenue beat(12)7
Avg Revenue beat(12)12.96%
Revenue beat(16)8
Avg Revenue beat(16)8.97%
PT rev (1m)2.98%
PT rev (3m)3.7%
EPS NQ rev (1m)-5.78%
EPS NQ rev (3m)-10.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.79%
Revenue NQ rev (1m)-23.91%
Revenue NQ rev (3m)-39.13%
Revenue NY rev (1m)-18.38%
Revenue NY rev (3m)-50.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 37.84
P/FCF N/A
P/OCF N/A
P/B 3.88
P/tB 3.88
EV/EBITDA N/A
EPS(TTM)-3.16
EYN/A
EPS(NY)-3.04
Fwd EYN/A
FCF(TTM)-2.92
FCFYN/A
OCF(TTM)-2.88
OCFYN/A
SpS0.38
BVpS3.67
TBVpS3.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -63.73%
ROE -75.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.41%
FCFM N/A
ROA(3y)-38.31%
ROA(5y)-38.76%
ROE(3y)-47.08%
ROE(5y)-55.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.35%
GM growth 5Y2.37%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.05%
Cap/Sales 10.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.88
Quick Ratio 8.83
Altman-Z 6.85
F-Score3
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)385.27%
Cap/Depr(5y)249.87%
Cap/Sales(3y)9.13%
Cap/Sales(5y)6.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.56%
EPS Next Y3.89%
EPS Next 2Y6.13%
EPS Next 3Y21.86%
EPS Next 5Y26.39%
Revenue 1Y (TTM)-27.5%
Revenue growth 3Y-8.83%
Revenue growth 5Y-1.85%
Sales Q2Q%-94.65%
Revenue Next Year-85.73%
Revenue Next 2Y17.25%
Revenue Next 3Y114.24%
Revenue Next 5Y94.23%
EBIT growth 1Y-66.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.22%
OCF growth 3YN/A
OCF growth 5YN/A

EYEPOINT INC / EYPT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EYEPOINT INC (EYPT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to EYPT.


What is the valuation status of EYEPOINT INC (EYPT) stock?

ChartMill assigns a valuation rating of 1 / 10 to EYEPOINT INC (EYPT). This can be considered as Overvalued.


How profitable is EYEPOINT INC (EYPT) stock?

EYEPOINT INC (EYPT) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for EYPT stock?

The Earnings per Share (EPS) of EYEPOINT INC (EYPT) is expected to grow by 3.89% in the next year.